Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial
The Lancet（2023）
摘要
National Institute for Health and Care Research and the Netherlands Organization for Health Research and Development.
更多查看译文
关键词
heparin,recurrent miscarriage,thrombophilia,alife2,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要